Microvesicles derived from mesenchymal stem cells: new hope of the treatment for ARDS / 中华危重病急救医学
Qihong CHEN; Ruiqiang ZHENG; Hualing WANG.
Chinese Critical Care Medicine
; (12): 774-777, 2017.
Artículo
en Zh
| WPRIM | ID: wpr-606955
Acute respiratory distress syndrome (ARDS) is a serious state threaten human health with a high mortality about 30%-40%. At present, there is no effective treatment for ARDS. Microvesicles derived from mesenchymal stem cells (MSC-MVs) have a heterogeneous subcellular structure secreted by MSCs. It plays an important role in the repair of tissue and organ damage.Recent studies have shown that MSC-MVs, played an important role in repairing lung injury, may replace MSC for cell therapy. Therefore MSC-MVs may bring new hope for ARDS treatment.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados